The Food and Drug Administration (FDA) has approved Linzess ® (linaclotide) for the treatment of irritable bowel syndrome with constipation (IBS-C) in patients 7 years of age and older. Previously, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback